Production of novel anti-recombinant human erythropoietin monoclonal antibodies and development of a sensitive enzyme-linked immunosorbent assay for detection of bioactive human erythropoietin

Shigehiro Yanagihara, Yuko Kori, Rika Ishikawa, Kazuhiro Kutsukake

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Erythropoietin (EPO) is a growth factor, regulating the proliferation and differentiation of erythroid progenitor cells. In this study, we generated five monoclonal antibodies (mAbs) that reacted specifically with recombinant human EPO (rhEPO). Epitope exclusion and other experiments showed that the mAbs obtained were divided into two groups, differing in recognition sites for rhEPO: group 1 mAbs recognize the N-terminal region of rhEPO, whereas group 2 mAbs seem to recognize a conformation-dependent epitope. Although most of the previously reported anti-EPO antibodies that recognized the N-terminal region of EPO lacked the EPO-neutralizing activity, the group 1 mAbs obtained here had the rhEPO-neutralizing activity. Therefore, the group 1 mAbs may be useful for future study on structure-function relationship of EPO. One of the group 2 mAbs, 5D11A, showed the highest affinity for rhEPO with KD value 0.52 nM and had the highest rhEPO-neutralizing activity. Using this mAb, we developed a reproducible and sensitive enzyme-linked immunosorbent assay for the quantification of bioactive rhEPO.

Original languageEnglish
Pages (from-to)181-196
Number of pages16
JournalJournal of Immunoassay and Immunochemistry
Volume29
Issue number2
DOIs
Publication statusPublished - Apr 2008

Fingerprint

Immunosorbents
Erythropoietin
Assays
Enzyme-Linked Immunosorbent Assay
Monoclonal Antibodies
Enzymes
Epitopes
Erythroid Precursor Cells
Conformations
Anti-Idiotypic Antibodies
Intercellular Signaling Peptides and Proteins
Antibodies

Keywords

  • Cell-based potency assay
  • Conformation- dependent epitope
  • Enzyme-linked immunosorbent assay
  • Monoclonal antibodies
  • Recombinant human erythropoietin
  • Validation

ASJC Scopus subject areas

  • Immunology
  • Pharmacology

Cite this

Production of novel anti-recombinant human erythropoietin monoclonal antibodies and development of a sensitive enzyme-linked immunosorbent assay for detection of bioactive human erythropoietin. / Yanagihara, Shigehiro; Kori, Yuko; Ishikawa, Rika; Kutsukake, Kazuhiro.

In: Journal of Immunoassay and Immunochemistry, Vol. 29, No. 2, 04.2008, p. 181-196.

Research output: Contribution to journalArticle

@article{15553bef77b04299b55ab4a974fdaaec,
title = "Production of novel anti-recombinant human erythropoietin monoclonal antibodies and development of a sensitive enzyme-linked immunosorbent assay for detection of bioactive human erythropoietin",
abstract = "Erythropoietin (EPO) is a growth factor, regulating the proliferation and differentiation of erythroid progenitor cells. In this study, we generated five monoclonal antibodies (mAbs) that reacted specifically with recombinant human EPO (rhEPO). Epitope exclusion and other experiments showed that the mAbs obtained were divided into two groups, differing in recognition sites for rhEPO: group 1 mAbs recognize the N-terminal region of rhEPO, whereas group 2 mAbs seem to recognize a conformation-dependent epitope. Although most of the previously reported anti-EPO antibodies that recognized the N-terminal region of EPO lacked the EPO-neutralizing activity, the group 1 mAbs obtained here had the rhEPO-neutralizing activity. Therefore, the group 1 mAbs may be useful for future study on structure-function relationship of EPO. One of the group 2 mAbs, 5D11A, showed the highest affinity for rhEPO with KD value 0.52 nM and had the highest rhEPO-neutralizing activity. Using this mAb, we developed a reproducible and sensitive enzyme-linked immunosorbent assay for the quantification of bioactive rhEPO.",
keywords = "Cell-based potency assay, Conformation- dependent epitope, Enzyme-linked immunosorbent assay, Monoclonal antibodies, Recombinant human erythropoietin, Validation",
author = "Shigehiro Yanagihara and Yuko Kori and Rika Ishikawa and Kazuhiro Kutsukake",
year = "2008",
month = "4",
doi = "10.1080/15321810801888506",
language = "English",
volume = "29",
pages = "181--196",
journal = "Journal of Immunoassay and Immunochemistry",
issn = "1532-1819",
publisher = "Taylor and Francis Ltd.",
number = "2",

}

TY - JOUR

T1 - Production of novel anti-recombinant human erythropoietin monoclonal antibodies and development of a sensitive enzyme-linked immunosorbent assay for detection of bioactive human erythropoietin

AU - Yanagihara, Shigehiro

AU - Kori, Yuko

AU - Ishikawa, Rika

AU - Kutsukake, Kazuhiro

PY - 2008/4

Y1 - 2008/4

N2 - Erythropoietin (EPO) is a growth factor, regulating the proliferation and differentiation of erythroid progenitor cells. In this study, we generated five monoclonal antibodies (mAbs) that reacted specifically with recombinant human EPO (rhEPO). Epitope exclusion and other experiments showed that the mAbs obtained were divided into two groups, differing in recognition sites for rhEPO: group 1 mAbs recognize the N-terminal region of rhEPO, whereas group 2 mAbs seem to recognize a conformation-dependent epitope. Although most of the previously reported anti-EPO antibodies that recognized the N-terminal region of EPO lacked the EPO-neutralizing activity, the group 1 mAbs obtained here had the rhEPO-neutralizing activity. Therefore, the group 1 mAbs may be useful for future study on structure-function relationship of EPO. One of the group 2 mAbs, 5D11A, showed the highest affinity for rhEPO with KD value 0.52 nM and had the highest rhEPO-neutralizing activity. Using this mAb, we developed a reproducible and sensitive enzyme-linked immunosorbent assay for the quantification of bioactive rhEPO.

AB - Erythropoietin (EPO) is a growth factor, regulating the proliferation and differentiation of erythroid progenitor cells. In this study, we generated five monoclonal antibodies (mAbs) that reacted specifically with recombinant human EPO (rhEPO). Epitope exclusion and other experiments showed that the mAbs obtained were divided into two groups, differing in recognition sites for rhEPO: group 1 mAbs recognize the N-terminal region of rhEPO, whereas group 2 mAbs seem to recognize a conformation-dependent epitope. Although most of the previously reported anti-EPO antibodies that recognized the N-terminal region of EPO lacked the EPO-neutralizing activity, the group 1 mAbs obtained here had the rhEPO-neutralizing activity. Therefore, the group 1 mAbs may be useful for future study on structure-function relationship of EPO. One of the group 2 mAbs, 5D11A, showed the highest affinity for rhEPO with KD value 0.52 nM and had the highest rhEPO-neutralizing activity. Using this mAb, we developed a reproducible and sensitive enzyme-linked immunosorbent assay for the quantification of bioactive rhEPO.

KW - Cell-based potency assay

KW - Conformation- dependent epitope

KW - Enzyme-linked immunosorbent assay

KW - Monoclonal antibodies

KW - Recombinant human erythropoietin

KW - Validation

UR - http://www.scopus.com/inward/record.url?scp=41149123150&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=41149123150&partnerID=8YFLogxK

U2 - 10.1080/15321810801888506

DO - 10.1080/15321810801888506

M3 - Article

C2 - 18360813

AN - SCOPUS:41149123150

VL - 29

SP - 181

EP - 196

JO - Journal of Immunoassay and Immunochemistry

JF - Journal of Immunoassay and Immunochemistry

SN - 1532-1819

IS - 2

ER -